Article
Characterization of a live-attenuated HCMV-based vaccine platform
17 Dec 2019
Abstract excerpt
Abstract Vaccines based on cytomegalovirus (CMV) demonstrate protection in animal models of infectious disease and cancer. Vaccine efficacy is associated with the ability of CMV to elicit and indefinitely maintain high frequencies of circulating effector memory T cells (TEM) providing continuous, life-long anti-pathogen immune activity. To allow for the clinical testing of human CMV (HCMV)-based vaccines we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
